Cerebrospinal fluid CXCL13 is a prognostic marker for aseptic meningitis

Journal of Neuroimmunology

Volumn 273, Issue 1-2, 2014, Pages 77-84

  Fujimori, Juichi ^a   Nakashima, Ichiro ^b   Kuroda, Hiroshi ^b   Fujihara, Kazuo ^b   Aoki, Masashi ^b  

^a Tohoku Medical and Pharmaceutical University Hospital   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aseptic meningitis; Aseptic meningoencephalitis; Cerebrospinal fluid (CSF); Chemokine; CXCL13; Cytokine

Indexed keywords

CXCL13 CHEMOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8;

ADULT; ARTICLE; ASEPTIC MENINGOENCEPHALITIS; CEREBROSPINAL FLUID EXAMINATION; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE COURSE; DISEASE MARKER; FEMALE; HUMAN; MALE; MENINGOENCEPHALITIS; PRIORITY JOURNAL; PROGNOSIS; VIRUS MENINGITIS;

ASEPTIC MENINGITIS; ASEPTIC MENINGOENCEPHALITIS; CEREBROSPINAL FLUID (CSF); CHEMOKINE; CXCL13; CYTOKINE;

ADULT; BIOLOGICAL MARKERS; BRAIN; CHEMOKINE CXCL13; CYTOKINES; FEMALE; HUMANS; IMMUNOGLOBULIN G; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MALE; MENINGITIS, ASEPTIC; MENINGOENCEPHALITIS; MIDDLE AGED; PROGNOSIS; ROC CURVE;

EID: 84904103366     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2014.05.008     Document Type: Article

References (30)

1. Alvarez E., Piccio L., Mikesell R.J., Klawiter E.C., Parks B.J., Naismith R.T., Cross A.H. CXCL13 is a biomarker of inflammation in multiple sclerosis, neuromyelitis optica, and other neurological conditions. Mult. Scler. 2013, 19:1204-1208.
2. Beleza P., Ribeiro M., Pereira J., Ferreira C., Jordão M.J., Almeida F. Probable acute disseminated encephalomyelitis due to Haemophilus influenzae meningitis. Dev. Med. Child Neurol. 2008, 50:388-391.
3. Bielekova B., Komori M., Xu Q., Reich D.S., Wu T. Cerebrospinal fluid IL-12p40, CXCL13 and IL-8 as a combinatorial biomarker of active intrathecal inflammation. PLoS One 2012, 7:e48370.
4. Bowman G.L., Kaye J.A., Moore M., Waichunas D., Carlson N.E., Quinn J.F. Blood-brain barrier impairment in Alzheimer disease: stability and functional significance. Neurology 2007, 68:1809-1814.
5. Bremell D., Mattsson N., Edsbagge M., Blennow K., Andreasson U., Wikkelsö C., Zetterberg H., Hagberg L. Cerebrospinal fluid CXCL13 in Lyme neuroborreliosis and asymptomatic HIV infection. BMC Neurol. 2013, 13:2.
6. Franciotta D., Zardini E., Ravaglia S., Piccolo G., Andreoni L., Bergamaschi R., Romani A., Tavazzi E., Naldi P., Ceroni M., Marchioni E. Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis. J. Neurol. Sci. 2006, 247:202-207.
7. Fujiki F., Tsuboi Y., Hori T., Yamada T. Aseptic meningitis as initial presentation of acute disseminated encephalomyelitis. J. Neurol. Sci. 2008, 272:129-131.
8. Gołabek V., Woźniakowska-Gesicka T., Sokołowska D. Acute disseminated encephalomyelitis in children as the result of aseptic meningitis - a report of two cases. Neurol. Neurochir. Pol. 2011, 45:180-187.
9. Höllinger P., Sturzenegger M., Mathis J., Schroth G., Hess C.W. Acute disseminated encephalomyelitis in adults: a reappraisal of clinical, CSF, EEG, and MRI findings. J. Neurol. 2002, 249:320-329.
10. Ichiyama T., Shoji H., Kato M., Sawaishi Y., Ozawa H., Matsubara T., Furukawa S. Cerebrospinal fluid levels of cytokines and soluble tumour necrosis factor receptor in acute disseminated encephalomyelitis. Eur. J. Pediatr. 2002, 161:133-137.
11. Ishizu T., Minohara M., Ichiyama T., Kira R., Tanaka M., Osoegawa M., Hara T., Furukawa S., Kira J. CSF cytokine and chemokine profiles in acute disseminated encephalomyelitis. J. Neuroimmunol. 2006, 175:52-58.
12. Jubelt B., Miller J.R. Viral infections. Merritt's Neurology 2000, 134-162. Lippincott Williams & Wilkins, Philadelphia. 10th ed. L.P. Rowland (Ed.).
13. Kowarik M.C., Cepok S., Sellner J., Grummel V., Weber M.S., Korn T., Berthele A., Hemmer B. CXCL13 is the major determinant for B cell recruitment to the CSF during neuroinflammation. J. Neuroinflammation 2012, 9:93.
14. Krumbholz M., Theil D., Cepok S., Hemmer B., Kivisäkk P., Ransohoff R.M., Hofbauer M., Farina C., Derfuss T., Hartle C., Newcombe J., Hohlfeld R., Meinl E. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment. Brain 2006, 129:200-211.
15. Krupp L.B., Tardieu M., Amato M.P., Banwell B., Chitnis T., Dale R.C., Ghezzi A., Hintzen R., Kornberg A., Pohl D., Rostasy K., Tenembaum S., Wassmer E., International Pediatric Multiple Sclerosis Study Group International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions. Mult. Scler. 2013, 19:1261-1267.
16. Kureshiro J., Kuzumoto Y., Aomatsu H., Kusunoki S. Acute meningoencephalitis caused by Streptococcus pneumoniae, mimicking acute disseminated encephalomyelitis. Rinsho Shinkeigaku 2008, 48:255-258.
17. Mandell G.L., Bennett J.E., Dolin R. Acute Meningitis. Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2010, 1189-1229. Elsevier, Amsterdam. Seventh edition.
18. Marchioni E., Ravaglia S., Piccolo G., Furione M., Zardini E., Franciotta D., Alfonsi E., Minoli L., Romani A., Todeschini A., Uggetti C., Tavazzi E., Ceroni M. Postinfectious inflammatory disorders: subgroups based on prospective follow-up. Neurology 2005, 65:1057-1065.
19. Marchioni E., Ravaglia S., Montomoli C., Tavazzi E., Minoli L., Baldanti F., Furione M., Alfonsi E., Bergamaschi R., Romani A., Piccolo L., Zardini E., Bastianello S., Pichiecchio A., Ferrante P., Delbue S., Franciotta D., Bono G., Ceroni M. Postinfectious neurologic syndromes: a prospective cohort study. Neurology 2013, 80:882-889.
20. Menge T., Hemmer B., Nessler S., Wiendl H., Neuhaus O., Hartung H.P., Kieseier B.C., Stuve O. Acute disseminated encephalomyelitis: an update. Arch. Neurol. 2005, 62:1673-1680.
21. Ohnishi H., Sawayama Y., Ariyama I., Yamaji K., Furusyo N., Hayashi J. Acute disseminated encephalomyelitis (ADEM) onset during meningitis and sepsis. Kansenshogaku Zasshi 2007, 81:577-581.
22. Okada H., Yoshioka K. Acute disseminated encephalomyelitis associated with meningitis due to Mycobacterium intracellulare. Intern. Med. 2010, 49:2113-2116.
23. Rainey-Barger E.K., Rumble J.M., Lalor S.J., Esen N., Segal B.M., Irani D.N. The lymphoid chemokine, CXCL13, is dispensable for the initial recruitment of B cells to the acutely inflamed central nervous system. Brain Behav. Immun. 2011, 25:922-931.
24. Rupprecht T.A., Koedel U., Fingerle V., Pfister H.W. The pathogenesis of lyme neuroborreliosis: from infection to inflammation. Mol. Med. 2008, 14:205-212.
25. Schwarz S., Mohr A., Knauth M., Wildemann B., Storch-Hagenlocher B. Acute disseminated encephalomyelitis: a follow-up study of 40 adult patients. Neurology 2001, 56:1313-1318.
26. Sonneville R., Klein I., de Broucker T., Wolff M. Post-infectious encephalitis in adults: diagnosis and management. J. Infect. 2009, 58:321-328.
27. Van Burgel N.D., Bakels F., Kroes A.C., van Dam A.P. Discriminating Lyme neuroborreliosis from other neuroinflammatory diseases by levels of CXCL13 in cerebrospinal fluid. J. Clin. Microbiol. 2011, 49:2027-2030.
28. Wang P.N., Fuh J.L., Liu H.C., Wang S.J. Acute disseminated encephalomyelitis in middle-aged or elderly patients. Eur. Neurol. 1996, 36:219-223.
29. Young N.P., Weinshenker B.G., Lucchinetti C.F. Acute disseminated encephalomyelitis: current understanding and controversies. Semin. Neurol. 2008, 28:84-94.
30. Zhong X., Wang H., Dai Y., Wu A., Bao J., Xu W., Cheng C., Lu Z., Qiu W., Hu X. Cerebrospinal fluid levels of CXCL13 are elevated in neuromyelitis optica. J. Neuroimmunol. 2011, 240:104-108.